Furthermore, when the effect of SVIP expression on the overall survival of breast cancer patients was analyzed considering the breast cancer subtype, lower SVIP mRNA expression levels were associated with a worse prognosis in the luminal A, luminal B, and TNBC subtypes (Figure 3F). This evidence concerns the gene SVIP and breast carcinoma.